The response of spermatogonial stem cells to fractionated X irradiation was studied in the various stages of the spermatogenic cycle of the CBA mouse. Fractionated doses of 2 + 2, 1 + 3, and 3 + 1 Gy with a 24-h interval between the doses were compared with a single dose of 4 Gy. The numbers of undifferentiated spermatogonia present 10 days after (the second) irradiation were taken as a measure of stem cell survival. Twenty-four hours after the first irradiation a sensitization was observed that was found to be stage-dependent. The greatest sensitization occurred in that part of the spermatogonial stem cell population that was in stages X-I during the first irradiation, i.e., the part that is stimulated to proliferate or actively proliferating at that time. In stages that were quiescent during the first irradiation (VI-VII), fractionation did not influence the response. Therefore, only the spermatogonial stem cells that are initially radioresistant become sensitized 24 h after irradiation. When two unequal doses (3 + 1 Gy or 1 + 3 Gy) are given, damage correlates with the size of the second dose, indicating that priming doses of 1 and 3 Gy are both capable of inducing the sensitizing effect.
Skip Nav Destination
Close
Article navigation
August 1993
Research Article|
August 01 1993
Differential Effects of Fractionated X Irradiation on Mouse Spermatogonial Stem Cells
Radiat Res (1993) 135 (2): 222–228.
Citation
Yvonne van der Meer, René Huiskamp, Jan A. G. Davids, Dirk G. de Rooij; Differential Effects of Fractionated X Irradiation on Mouse Spermatogonial Stem Cells. Radiat Res 1 August 1993; 135 (2): 222–228. doi: https://doi.org/10.2307/3578298
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner